I-KaiBiLi COVID-19 Neutralization Ab+ Rapid Test
Isingeniso
Ama-coronavirus anoveli awohlobo lwe-β.I-COVID-19 yisifo esithathelwanayo sokuphefumula esinamandla.I-SARS-CoV-2 inamaprotheni esakhiwo amaningana afaka i-spike (S), imvilophu (E), ulwelwesi (M) kanye ne-nucleocapsid (N).Iphrotheni ye-spike (S) iqukethe isizinda esibopha i-receptor (RBD), esibophezelekile ukuqaphela i-cell surface receptor, i-angiotensin converting enzyme-2 (ACE2).Kutholwe ukuthi i-RBD ye-SARS-CoV-2 spike protein isebenzisana ngokuqinile ne-ACE2 receptor yomuntu okuholela ku-endocytosis kumaseli aphethe wamaphaphu ajulile kanye nokuphindaphindeka kwegciwane.Ukutheleleka nge-SARS-CoV-2 noma ukugoma kuqala impendulo yokuzivikela komzimba, okubandakanya ukukhiqizwa kwe-anti-RBD IgG antibody egazini.I-antibody efihliwe ihlinzeka ngokuvikeleka ezifweni zesikhathi esizayo ezivela kumagciwane, ngoba ihlala ohlelweni lokujikeleza kwegazi izinyanga kuya eminyakeni ngemva kokutheleleka noma ukugonywa futhi izobopha ngokushesha futhi ngokuqinile ku-pathogen ukuze ivimbele ukungena kwamangqamuzana nokuphindaphinda.Ukusebenza komgomo ka-80% uma kuqhathaniswa ne-COVID-19 eyizimpawu eziyinhloko kungafinyelelwa ngezinga le-antibody elingu-506 BAU/mL le-anti-RBD IgG.
Ukutholwa
I-KaiBiLi COVID-19 Neutralization Ab+ Rapid Test iyi-lateral flow chromatographic immunoassay yokutholwa kwe-semiquantitative kwe-anti-RBD IgG antibody kuya ku-SARS-CoV-2 egazini lomuntu lonke, i-serum noma isampula se-plasma.Idivayisi ingathola ukugxila kwe-anti-RBD IgG antibody enkulu noma elingana no-506 BAU/mL njengokugxiliswa kwamasosha omzimba asebenzayo kanye no-5 BAU/mL njengomkhawulo wokutholwa.
Isifanekiso
Igazi eliphelele, i-serum noma i-plasma
Umkhawulo Wokutholwa (LoD)
5 BAU/mL
Isikhathi semiphumela
Funda imiphumela ngemizuzu eyi-15 futhi ungabi ngaphezu kwemizuzu engama-30.
Izimo zokugcina ikhithi
2~30°C.
Okuqukethwe
Incazelo | Qty |
Hlola amadivayisi | ama-pcs angu-40 |
I-dropper yepulasitiki | ama-pcs angu-40 |
Isampula sebhafa | 1 isitsha |
Faka iphakheji | 1 ama-pcs |
Uku-oda Ulwazi
Umkhiqizo | Ikati.No. | Okuqukethwe |
KaiBiLiTMI-COVID-19 Neutralization Ab+ | P231145 | Izivivinyo ezingama-40 |